These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 7039632
1. Intraperitoneal insulin in the diabetic continuous ambulatory peritoneal dialysis (CAPD) patient - nursing management. Adair CM. AANNT J; 1982 Apr; 9(2):62-3. PubMed ID: 7039632 [No Abstract] [Full Text] [Related]
2. Diabetes, intraperitoneal insulin, and CAPD. Cohen IM, Lee S. Clin Exp Dial Apheresis; 1981 Apr; 5(3):269-75. PubMed ID: 7037250 [Abstract] [Full Text] [Related]
3. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin. Madden MA, Zimmerman SW, Simpson DP. Am J Nephrol; 1982 Apr; 2(3):133-9. PubMed ID: 6758585 [Abstract] [Full Text] [Related]
4. Intraperitoneal insulin: new alternative for diabetic CAPD patients. Bandel-Walcer R, Myers C, Malgaonkar S, Lyman N. AANNT J; 1982 Aug; 9(4):31-5. PubMed ID: 7049191 [No Abstract] [Full Text] [Related]
5. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. Quellhorst E. J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768 [Abstract] [Full Text] [Related]
6. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis]. Riambau E, Aubia J, Llorach I, Lloveras J, Masramón J, Orfila A, Llorach M. Rev Clin Esp; 1982 Mar 15; 164(5):333-4. PubMed ID: 7048442 [No Abstract] [Full Text] [Related]
8. Continuous ambulatory peritoneal dialysis (CAPD) in diabetics with end-stage renal disease. Amair P, Khanna R, Digenis G, Oreopoulos DG. Int J Artif Organs; 1982 Mar 15; 5(2):81-2. PubMed ID: 7047411 [No Abstract] [Full Text] [Related]
9. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD. Rottembourg J, Balducci A, Baumelou A, Jacq D, Agrafiotis A, Slama G. Proc Clin Dial Transplant Forum; 1980 Mar 15; 10():305-7. PubMed ID: 7050993 [No Abstract] [Full Text] [Related]
10. Intraperitoneal insulin during peritoneal dialysis for patients with diabetes and renal failure. Krothapalli R, Patel HS, Lacke C, Payne W, Knight TF, Senekjian HO, Weinman EJ. South Med J; 1983 Apr 15; 76(4):512-4. PubMed ID: 6340216 [No Abstract] [Full Text] [Related]
18. Glucose, insulin and C-peptide kinetics during continuous ambulatory peritoneal dialysis. Wideröe TE, Smeby LC, Myking OL, Wessel-Aas T. Proc Eur Dial Transplant Assoc; 1983 Oct 17; 20():195-200. PubMed ID: 6361735 [Abstract] [Full Text] [Related]
19. A potential hazard of U 100 insulin syringes in diabetic on CAPD. Fisher J, Wilson JM, Walls J. Lancet; 1983 Dec 10; 2(8363):1363. PubMed ID: 6139692 [No Abstract] [Full Text] [Related]
20. Intermediary metabolism and glycemic control in insulin-dependent diabetic uremic patients treated by continuous peritoneal dialysis. Spotti D, Slaviero G, La Rocca E, Cantaluppi A, Castelnovo C, Micossi P, Quartagno R, Melandri M, Pozza G, Ponticelli C. Nephron; 1988 Dec 10; 49(3):219-22. PubMed ID: 3041295 [Abstract] [Full Text] [Related] Page: [Next] [New Search]